NASD · Healthcare · Medical Devices · USA
Neogen Corp is a mid cap company (market value between $2 billion and $10 billion) in the Medical Devices industry.
Neogen develops, manufactures and markets diagnostic test kits and consumables for food and animal safety. Its Food Safety segment provides testing solutions to detect pathogens, toxins and allergens in food and feed. Its Animal Safety segment offers veterinary instruments, pharmaceuticals, vaccines, parasiticides, and rodent and insect control products to livestock producers, veterinarians and retailers worldwide.
From its FY2026 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Neogen Corp stock.
Overvalued: intrinsic value $1.90 per share, market price $10.90, margin of safety -473.2% (as of 2026-11-17).
Its through-the-cycle earnings (16.0% median margin), capitalised at 11.1% with no growth, values the shares at $1.90; the price of $10.90 is 473% above that value.
17 more funds hold it; the full list is part of the paid plan.
All 140 Medical Devices stocks
51 more in this industry show a wider margin of safety.
NEOG is overvalued (as of the 2026-11-17 close). Its through-the-cycle earnings (16.0% median margin), capitalised at 11.1% with no growth, values the shares at $1.90; the price of $10.90 is 473% above that value.
$1.90 per share (as of the 2026-11-17 close), against a market price of $10.90. That is a margin of safety of -473.2%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.